[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350369-105":59,"doc-detail-350369-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","gene-amplication-in-the-premalignant-stages-of-non-small-cell-lung-cancer-development","Gene ampliﬁcation in the premalignant stages of non-small cell lung cancer development","","Early intervention in non-small cell lung cancer depends on identifying high-risk premalignant lesions before clinical diagnosis. Somatic copy-number alterations are established drivers, and accumulating evidence shows that gene amplification events emerge early during lung carcinogenesis, including minimally invasive lesions. These early events can promote clonal expansion, increase genomic instability, and accelerate progression. This mini review synthesizes current evidence for early amplifications in LUAD and LUSC, discusses translational relevance for detection and intervention, and outlines priorities and challenges for future research.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gene-amplication-in-the-premalignant-stages-of-non-small-cell-lung-cancer-development/350369/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gene-amplication-in-the-premalignant-stages-of-non-small-cell-lung-cancer-development/350369.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are early gene amplification events important in non-small cell lung cancer?","Question",{"text":113,"@type":114},"They emerge early during lung carcinogenesis, can provide growth advantages, and may accelerate progression well before clinical diagnosis, making them promising biomarkers for risk stratification and early detection.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the review define gene amplification in cancer genomics?",{"text":118,"@type":114},"It defines gene amplification as somatic increases in DNA copy-number in a genomic segment covering one or more genes, distinguishing focal high-level amplifications from lower-level gains such as arm-level gains and whole-chromosome polysomy.",{"name":120,"@type":111,"acceptedAnswer":121},"What clinical research goals does the article connect to premalignant gene amplifications?",{"text":122,"@type":114},"The review links early amplifications to identifying high-risk lesions in screening settings, refining risk stratification, and exposing vulnerabilities that could support prevention-oriented early intervention.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350369,1790380794,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Mini Review  \nPUBLISHED 20 May 2026  \nDOI 10.3389/fonc.2026.1803576  \nOPEN ACCESS  \nEDITED BY  \nFrederick Vizeacoumar,  \nUniversity of Saskatchewan, Canada  \nREVIEWED BY  \nStijn Vanstraelen,  \nUniversity Hospitals Leuven, Belgium Bingxin Lu,  \nUniversity of Surrey, United Kingdom  \n*CORRESPONDENCE  \nVanessa G. P. Souza  \n[vsouza@bccrc.ca](vsouza@bccrc.ca)  \n†These authors have contributed equally to this work  \nRECEIVED 04 February 2026  \nREVISED 08 April 2026  \nACCEPTED 29 April 2026  \nPUBLISHED 20 May 2026  \nCITATION  \nSouza VGP, Be´nard KH, Stewart GL, Enﬁeld KSS, Lockwood WW and Lam WL (2026) Gene ampliﬁcation in the premalignant stages of non-small cell lung cancer development.  \nFront. Oncol. 16:1803576 .  \ndoi: 10.3389/fonc.2026.1803576  \nCOPYRIGHT  \n© 2026 Souza, Be´nard, Stewart, Enﬁeld, Lockwood and Lam. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGene ampliﬁcation in the premalignant stages of non-small cell lung cancer development  \nVanessa G. P. Souza 1*†, Katya H. B´enard 1,2†, Greg L. Stewart 1, Katey S. S. Enﬁeld1,2,3, William W. Lockwood 1,2,3  \nand Wan L. Lam 1,2,3  \n1 British Columbia Cancer Research Institute, Vancouver, BC, Canada, 2 Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada, 3 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada  \nLung cancer remains the leading cause of cancer-related mortality worldwide. Over the past decade, major advances in targeted and immune-based therapies have improved outcomes for patients with advanced non-small cell lung cancer (NSCLC) . However, further reducing mortality will require shifting intervention to the earliest, most curable stages of disease. Somatic copy-number alterations (SCNAs) are established drivers of NSCLC, and recent publications add to the growing evidence that gene ampliﬁcations, among the most frequent SCNAs in lung cancer, emerge early in carcinogenesis, including in premalignant and minimally invasive lesions. These early events can confer growth advantages that support clonal expansion, increase genomic instability, and propel progression toward invasive malignancy long before clinical diagnosis. Consequently, early gene ampliﬁcations represent a promising class of biomarkers for identifying high-risk lesions, reﬁning risk stratiﬁcation in screening settings, and exposing vulnerabilities amenable to early intervention. In this article, we synthesize current evidence on early ampliﬁcation events in lung adenocarcinoma and lung squamous cell carcinoma, discuss their translational relevance for early detection and intervention, and outline key challenges and priorities for future research.  \nKEYWORDS  \ncancer interception, early carcinogenesis, gene ampliﬁcation, lung adenocarcinoma (LUAD), lung cancer, lung squamous cell carcinoma (LUSC), premalignant lesions, somatic copy-number alterations  \n1 Introduction  \nRecent advances in targeted therapies and immune checkpoint inhibitors have improved outcomes in lung cancer; nevertheless, lung cancer remains the leading cause of cancer-related mortality worldwide (1) . Major efforts have focused on detecting disease atthe earliest clinical stages, when tumors are more likely to be curable and a broader range of therapeutic strategies can be applied (2) .  \nGene ampliﬁcations are among the most frequent genomic alterations in lung cancer and are well established as drivers of oncogenesis (3–10) . Recent studies indicate that gene ampliﬁcations arise early during lung carcinogenesis, including in premalignant ","cbCaij3CpJ8RE2my","https://ap.wps.com/l/cbCaij3CpJ8RE2my","pdf",5488824,13,"English","# Introduction\n# Gene amplification\n## Segmental DNA amplifications","[{\"question\":\"Why are early gene amplification events important in non-small cell lung cancer?\",\"answer\":\"They emerge early during lung carcinogenesis, can provide growth advantages, and may accelerate progression well before clinical diagnosis, making them promising biomarkers for risk stratification and early detection.\"},{\"question\":\"How does the review define gene amplification in cancer genomics?\",\"answer\":\"It defines gene amplification as somatic increases in DNA copy-number in a genomic segment covering one or more genes, distinguishing focal high-level amplifications from lower-level gains such as arm-level gains and whole-chromosome polysomy.\"},{\"question\":\"What clinical research goals does the article connect to premalignant gene amplifications?\",\"answer\":\"The review links early amplifications to identifying high-risk lesions in screening settings, refining risk stratification, and exposing vulnerabilities that could support prevention-oriented early intervention.\"}]","Gene ampliﬁcation in the premalignant stages of non-small cell lung cancer development | PDF",1790088707,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/880dc225c543fd322e323558391f70c5.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/116a7f96bf742853be6c9345733cee67.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4c609fd15663bceed02e58940524705.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f1400adcb4b56ef9d031b735f4895a.webp",980,1385]